htlr4 cells Search Results


hek blue seap reporter cell lines  (InvivoGen)
96
InvivoGen hek blue seap reporter cell lines
Hek Blue Seap Reporter Cell Lines, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hek blue seap reporter cell lines/product/InvivoGen
Average 96 stars, based on 1 article reviews
hek blue seap reporter cell lines - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
htlr4 conjugated phycoerythrin (pe  (Becton Dickinson)
90
Becton Dickinson htlr4 conjugated phycoerythrin (pe
Htlr4 Conjugated Phycoerythrin (Pe, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/htlr4 conjugated phycoerythrin (pe/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
htlr4 conjugated phycoerythrin (pe - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hek293-htlr4-gfp stable cell lines  (Aurogene Srl)
90
Aurogene Srl hek293-htlr4-gfp stable cell lines
Hek293 Htlr4 Gfp Stable Cell Lines, supplied by Aurogene Srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hek293-htlr4-gfp stable cell lines/product/Aurogene Srl
Average 90 stars, based on 1 article reviews
hek293-htlr4-gfp stable cell lines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hek-bluetm htlr4 cells  (Vivogen Biotechnology Inc)
90
Vivogen Biotechnology Inc hek-bluetm htlr4 cells
Macrophage activation by violacein-killed tumor cell supernatant. HCT116, Huh7, and PANC-1 cells were treated with 50 µM violacein or oxaliplatin for 4 h before the media was changed. Then, 24 h after treatment, supernatants from untreated (co) and compound-treated cells were collected, and dead cells were removed. (A-C) RAW-Blue™, (D-F) THP1-XBlue™, (G, H) HEK-Blue™ <t>hTLR4,</t> and (J-L) HEK-Blue™ Null2 reporter cells were incubated with the respective dead tumor cell-conditioned medium (dTCM, 50% v/v) or LPS (100 ng/ml for RAW-Blue™ and 10 ng/ml for THP1X-Blue™, HEK-Blue™ hTLR4, and HEK-Blue™ Null2) for 24 h. The activation of the reporter cells was determined by colorimetric QUANTI-Blue™.
Hek Bluetm Htlr4 Cells, supplied by Vivogen Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hek-bluetm htlr4 cells/product/Vivogen Biotechnology Inc
Average 90 stars, based on 1 article reviews
hek-bluetm htlr4 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hek-blue htlr4 cells  (InvivoGen)
96
InvivoGen hek-blue htlr4 cells
Macrophage activation by violacein-killed tumor cell supernatant. HCT116, Huh7, and PANC-1 cells were treated with 50 µM violacein or oxaliplatin for 4 h before the media was changed. Then, 24 h after treatment, supernatants from untreated (co) and compound-treated cells were collected, and dead cells were removed. (A-C) RAW-Blue™, (D-F) THP1-XBlue™, (G, H) HEK-Blue™ <t>hTLR4,</t> and (J-L) HEK-Blue™ Null2 reporter cells were incubated with the respective dead tumor cell-conditioned medium (dTCM, 50% v/v) or LPS (100 ng/ml for RAW-Blue™ and 10 ng/ml for THP1X-Blue™, HEK-Blue™ hTLR4, and HEK-Blue™ Null2) for 24 h. The activation of the reporter cells was determined by colorimetric QUANTI-Blue™.
Hek Blue Htlr4 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hek-blue htlr4 cells/product/InvivoGen
Average 96 stars, based on 1 article reviews
hek-blue htlr4 cells - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
puromycin  (InvivoGen)
99
InvivoGen puromycin
Macrophage activation by violacein-killed tumor cell supernatant. HCT116, Huh7, and PANC-1 cells were treated with 50 µM violacein or oxaliplatin for 4 h before the media was changed. Then, 24 h after treatment, supernatants from untreated (co) and compound-treated cells were collected, and dead cells were removed. (A-C) RAW-Blue™, (D-F) THP1-XBlue™, (G, H) HEK-Blue™ <t>hTLR4,</t> and (J-L) HEK-Blue™ Null2 reporter cells were incubated with the respective dead tumor cell-conditioned medium (dTCM, 50% v/v) or LPS (100 ng/ml for RAW-Blue™ and 10 ng/ml for THP1X-Blue™, HEK-Blue™ hTLR4, and HEK-Blue™ Null2) for 24 h. The activation of the reporter cells was determined by colorimetric QUANTI-Blue™.
Puromycin, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/puromycin/product/InvivoGen
Average 99 stars, based on 1 article reviews
puromycin - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


Macrophage activation by violacein-killed tumor cell supernatant. HCT116, Huh7, and PANC-1 cells were treated with 50 µM violacein or oxaliplatin for 4 h before the media was changed. Then, 24 h after treatment, supernatants from untreated (co) and compound-treated cells were collected, and dead cells were removed. (A-C) RAW-Blue™, (D-F) THP1-XBlue™, (G, H) HEK-Blue™ hTLR4, and (J-L) HEK-Blue™ Null2 reporter cells were incubated with the respective dead tumor cell-conditioned medium (dTCM, 50% v/v) or LPS (100 ng/ml for RAW-Blue™ and 10 ng/ml for THP1X-Blue™, HEK-Blue™ hTLR4, and HEK-Blue™ Null2) for 24 h. The activation of the reporter cells was determined by colorimetric QUANTI-Blue™.

Journal: Frontiers in Oncology

Article Title: Characterization of Anti-Cancer Activities of Violacein: Actions on Tumor Cells and the Tumor Microenvironment

doi: 10.3389/fonc.2022.872223

Figure Lengend Snippet: Macrophage activation by violacein-killed tumor cell supernatant. HCT116, Huh7, and PANC-1 cells were treated with 50 µM violacein or oxaliplatin for 4 h before the media was changed. Then, 24 h after treatment, supernatants from untreated (co) and compound-treated cells were collected, and dead cells were removed. (A-C) RAW-Blue™, (D-F) THP1-XBlue™, (G, H) HEK-Blue™ hTLR4, and (J-L) HEK-Blue™ Null2 reporter cells were incubated with the respective dead tumor cell-conditioned medium (dTCM, 50% v/v) or LPS (100 ng/ml for RAW-Blue™ and 10 ng/ml for THP1X-Blue™, HEK-Blue™ hTLR4, and HEK-Blue™ Null2) for 24 h. The activation of the reporter cells was determined by colorimetric QUANTI-Blue™.

Article Snippet: HEK-BlueTM hTLR4 cells and HEK-BlueTM Null2 cells (In vivoGen) were grown in DMEM supplemented with 10% heat-inactivated FCS (30 min at 56°C), 100 U/ml penicillin/streptomycin, 2 mM glutamine, 100 μg/ml Normocin, and 1x HEK-BlueTM Selection.

Techniques: Activation Assay, Incubation